Geron Corporation (GERN) Financials
GERN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 394.1 million | 146.1 million |
2023-09-30 | 413.0 million | 122.4 million |
2023-06-30 | 415.3 million | 116.9 million |
2023-03-31 | 424.9 million | 98.8 million |
GERN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -40.4 million | 4.4 million |
2023-09-30 | -51.0 million | 7.2 million |
2023-06-30 | -29.8 million | 3.9 million |
2023-03-31 | -46.7 million | 3.0 million |
GERN Net Income
No data available :(
GERN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 334.8 million | - | 4.0 million |
2023-09-30 | 313.5 million | - | 4.1 million |
2023-06-30 | 371.4 million | - | 4.3 million |
2023-03-31 | 381.1 million | 51.4 million | 4.4 million |
GERN Shares Outstanding
GERN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 64000 | 32.9 million | 21.4 million | 241000 |
2023-09-30 | 192000 | 29.4 million | 18.4 million | - |
2023-06-30 | 202000 | 35.5 million | 16.5 million | - |
2023-03-31 | 372000 | 27.2 million | 12.9 million | - |
GERN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 23000 | 241000 |
2023-09-30 | 164000 | 29.4 million |
2023-06-30 | 29000 | 275000 |
2023-03-31 | 21000 | 251000 |
GERN
Price: $3.77
52 week price:
Earnings Per Share: -0.32 USD
P/E Ratio: -5.56
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 535483
Ebitda: -6.9 millionMarket Capitalization: 2.0 billion